DAUNORUBICIN - AND MEDICATION

Daunorubicin



Editor'S Choice
Treatment for Ectodermal Dysplasia
Treatment for Ectodermal Dysplasia
Daunorubicin is the active substance of an antineoplastic medicine known commercially as Daunoblastine. This Injectable drug is indicated for the treatment of blood cancer, since its action tries to prevent the cancer cells from getting to the other organs through the bloodstream. Indications of Daunorubicin Lymphocytic leukemia; acute nonlymphocytic leukemia